Fri, Jul 13, 2012, 6:52 AM EDT - U.S. Markets open in 2 hrs 38 mins
Sorry, I could not read the content fromt this page.
Showing posts with label Investment. Show all posts
Showing posts with label Investment. Show all posts
Sunday, July 15, 2012
Friday, June 29, 2012
Zacks Investment Ideas feature highlights: ProShares Ultra Health Care ETF, ProShares UltraShort Health Care ETF ...
For Immediate Release
Chicago, IL –June 28, 2012 – Today, Zacks Investment Ideas feature highlights Features: ProShares Ultra Health Care ETF (RXL), ProShares UltraShort Health Care ETF (RXD), Direxion Daily Healthcare Bull 3x Shares (CURE) and Direxion Daily Healthcare Bear 3x Shares (SICK).
Health Care ETFs & the Future of Obamacare
In summary, if the individual mandate is thrown out, it looks likely to spell bad news for the entire sector. That is because the mandate would add a ton of cheap-to-ensure people to the rolls of HMOs while it would drive up demand for devices, services and drugs, helping pretty much the entire industry.
If the bill is upheld in its entirety, a much more mixed outlook could be the result. With that being said, it will definitely be a big win for pharma, and to an extent healthcare providers and service companies as well. However, medical device makers look likely to be hurt by the ruling due to new taxes, while biotech could suffer from a similar issue as well (see Medical Device ETFs: A Better Way To Play Health Care?).
Lastly, if the entire bill is deemed unconstitutional, which at this point seems unlikely, it also could produce a mixed result. Broad health care is likely to stay about even, but investors could see a modest uptick for device makers and biotech, while pharma and the HMO market could be losers due to lower demand for their services.
Beyond these unleveraged choices, investors also have a few ways to play the decision with leverage. In total, there are four ETFs in this segment of the fund world, offering investors exposure to both bull and bear 2x strategies as well as both directions in 3x form as well:
ProShares Ultra Health Care ETF (RXL)/ ProShares UltraShort Health Care ETF (RXD)- These two products track, respectively, the 2x and -2x versions of the Dow Jones Health Care Index. This benchmark is heavily weighted towards big pharma, but it is still relatively spread out among its 122 securities.
Direxion Daily Healthcare Bull 3x Shares (CURE)/Direxion Daily Healthcare Bear 3x Shares (SICK)- These two products track, respectively, the 3x and -3x versions of the Health Care Select Sector Index. Much like their ProShares counterparts, these funds have a focus on big pharma, although they have a heavier level of concentration in their top securities, only holding 52 stocks in total (read Understanding Leveraged ETFs).
While the volumes on these products aren’t exactly the most robust in the ETF world-- suggesting relatively wide bid ask spreads-- they could see higher levels of activity leading up to and immediately following the in-focus decision. Given this, these products could be the way to play the situation, although investors should be prepared for a great deal of volatility and uncertainty no matter what health care stocks or ETFs they hold immediately following the pivotal Supreme Court ruling.
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Len Zacks. The company continually processes stock reports issued by 3,000 analysts from 150 brokerage firms. It monitors more than 200,000 earnings estimates, looking for changes.
Then when changes are discovered, they’re applied to help assign more than 4,400 stocks into five Zacks Rank categories: #1 Strong Buy, #2 Buy, #3 Hold, #4 Sell, and #5 Strong Sell. This proprietary stock picking system; the Zacks Rank, continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter Profit from the Pros. In short, it’s your steady flow of profitable ideas GUARANTEED to be worth your time. Get your free subscription to Profit from the Pros at: http://at.zacks.com/?id=7298
Follow us on Twitter: http://twitter.com/ZacksResearch
Join us on Facebook: http://www.facebook.com/ZacksInvestmentResearch
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Media Contact
Zacks Investment Research
800-767-3771 ext. 9339
support@zacks.com
http://www.zacks.com
Read the analyst report on RXL
Read the analyst report on RXD
Read the analyst report on CURE
Read the analyst report on SICK
Zacks Investment Research
More From Zacks.com
Thursday, February 23, 2012
Health Evolution Partners Makes Investment in Freedom Innovations, LLC
SAN FRANCISCO--(BUSINESS WIRE)--
Health Evolution Partners, a health care private equity firm, announced today that it has acquired a majority interest in Freedom Innovations, LLC (“Freedom”). Freedom, based in Irvine, California, is a leading provider of premium high-technology prosthetic devices and is focused on developing world-class solutions for individuals with lower limb amputations. Freedom’s senior management team will continue their leadership of the organization, and will remain significant shareholders in the company. Financial terms of the transaction were not disclosed.
“We are very excited to partner with Freedom,” said Ned Brown, Investment Partner of Health Evolution Partners. “Freedom develops, manufactures, and has successfully commercialized, a broad and attractive portfolio of proprietary lower limb prosthetic devices. The company provides a tremendous platform for expansion in a dynamic and growing market, and has a robust pipeline of new products. We have been impressed with Freedom’s strong management team and employees; they have an outstanding track record of innovation and development, along with superior commercial execution and customer service. We look forward to working with them.”
“Health Evolution Partners is an ideal partner for Freedom,” said Maynard Carkhuff, Chief Executive Officer of Freedom. “Their extensive background in the medical device industry, combined with their strategic insight, and the firm’s total-systems approach to healthcare investing will be extremely valuable to Freedom as we continue to execute our growth strategy. We believe that Health Evolution Partners will be able to help accelerate Freedom’s growth through their broad-scale healthcare systems, strategic, operational, reimbursement, and commercial sales and marketing experience. Furthermore, their strong relationships with key decision-makers in the healthcare industry, both in the U.S. and internationally, will be highly valuable.”
As part of the transaction, and to finance further growth opportunities for Freedom, Health Evolution Partners facilitated the successful completion of new senior credit facilities. The senior credit facilities were led by Madison Capital Funding LLC and included BMO Capital Markets as Co-Lead Arranger.
Health Evolution Partners focuses on creating strong partnerships with high growth companies and exceptional management teams in the healthcare industry. The firm seeks to invest in platforms where the expertise and experience of the firm’s operating and transaction principals can contribute to accelerating the growth and value of the businesses. Freedom is Health Evolution Partner’s ninth Growth Fund investment. Health Evolution Partner’s previous investments include AOS, CambridgeSoft, CenseoHealth, Halcyon Healthcare, Kisimul, Mollen Immunization Clinics, Optimal IMX, and Prolacta Bioscience.
“We are enthusiastic about Freedom Innovations, and look forward to working with them to continue their global growth,” said David J. Brailer, Ph.D., M.D., Chairman of Health Evolution Partners. “Freedom adds undisputed value to its patients and to the overall health care system. It is led by a strong and proven management team, and is poised to take major steps forward as a commercial leader in its space. It is, in short, the kind of company that we want to work with and to have in our portfolio.”
About Health Evolution Partners | www.healthevolutionpartners.com
Health Evolution Partners buys and invests in rapidly growing companies that are commercial leaders in the health care industry. We invest around the globe and across the health economy, including services, information technology, and life sciences. We form close working partnerships with outstanding management teams and connect our companies to our network of CEOs, policy makers, and thought leaders. For more information on Health Evolution Partners, visit www.healthevolutionpartners.com.
Wednesday, February 1, 2012
InTouch Health Receives $6 Million Investment from iRobot Corp.
SANTA BARBARA, Calif.--(BUSINESS WIRE)-- InTouch Technologies, Inc. (dba. InTouch Health), a leading provider of acute healthcare remote presence solutions, announced today that iRobot Corp., a leader in delivering robot technology-based solutions, has made a $6 million investment in the Company.
InTouch Health and iRobot have a joint development and licensing agreement, formalized in July 2011, to explore opportunities for healthcare applications of robotic technology by uniting complementary expertise and technologies across each company’s intellectual property portfolio. InTouch Health’s ten years of experience in robotic telemedicine solutions coupled with iRobot’s expertise in robot navigation, mobility and manipulation can prove to be a potent combination in developing purpose-built robots for the healthcare industry. This collaboration will allow InTouch Health to advance its healthcare-centric robotic platform to a new level of mobility and utility, which will allow for even greater ease of use by clinicians.
“As evident from the demonstrations of its Ava robotic platform, iRobot is the industry leader in robot navigation, mobility and manipulation,” said Yulun Wang, Chairman and CEO of InTouch Health. “Working together, InTouch Health and iRobot will pioneer superior remote presence in healthcare settings, providing anytime/anywhere patient care in hospital ED’s, ICU’s, patient wards, and operating and procedure rooms.”
“With over 400 hospitals in the U.S. and around the world utilizing its remote presence products, InTouch Health is in a very unique position in the healthcare field with its FDA-cleared telemedicine devices,” said Colin Angle, Chairman and CEO of iRobot. “iRobot’s investment in InTouch Health will further align these two leaders, creating a best of breed partnership that will develop robots for remote presence healthcare and assistive technologies for the elderly.”
About InTouch Health
InTouch Health provides comprehensive telemedicine solutions and expertise that enable physicians to perform real-time consults with patients. Through a single portal, physicians can access InTouch Health’s purpose-built, FDA-cleared remote presence (“RP”) devices to provide care anywhere across the healthcare continuum: EDs, ICUs, procedure rooms, patient wards, clinics, ambulances, and homes. The InTouch Health Remote Presence telemedicine network is powered through its SureCONNECT® cloud-based infrastructure providing unparalleled connection quality and reliability, interoperability, workflow imaging and documentation, and service and support. Wherever access to medical expertise is limited, InTouch Health's Remote Presence telemedicine solutions can effectively extend the physician's reach to manage patient care, thereby removing critical time and distance barriers.
The Company has more than 400 hospital locations on six continents enrolled in its Remote Presence network for the delivery of telemedicine services such as stroke, critical care, cardiology, trauma, pediatrics, neonatology, mental health, language translation, clinical education and surgical/procedure mentoring. For more information about InTouch Health, please visit www.intouchhealth.com.
About iRobot Corp.
iRobot designs and builds robots that make a difference. The company’s home robots help people find smarter ways to clean, and its government and industrial robots protect those in harm’s way. iRobot’s consumer and military robots feature iRobot Aware® robot intelligence systems, proprietary technology incorporating advanced concepts in navigation, mobility, manipulation and artificial intelligence. For more information about iRobot, please visit www.irobot.com.
Subscribe to:
Posts (Atom)